BOLD (Boundless Bio) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Boundless Bio's Free Cash Flow for the three months ended in Dec. 2024 was $-16.03 Mil. Boundless Bio's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Boundless Bio's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Boundless Bio's current FCF Yield % is -220.31%.

The historical rank and industry rank for Boundless Bio's FCF Margin % or its related term are showing as below:

BOLD's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -129.705
* Ranked among companies with meaningful FCF Margin % only.

Boundless Bio FCF Margin % Historical Data

The historical data trend for Boundless Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio FCF Margin % Chart

Boundless Bio Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Boundless Bio Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Boundless Bio's FCF Margin %

For the Biotechnology subindustry, Boundless Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boundless Bio's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Boundless Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Boundless Bio's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Boundless Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Boundless Bio's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-63.377	/	0
	=	%

Boundless Bio's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-16.029	/	0
	=	%

Boundless Bio FCF Margin % Related Terms

Thank you for viewing the detailed overview of Boundless Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Boundless Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9880 Campus Point Drive, Suite 120, San Diego, CA, USA, 92121

Website

https://www.boundlessbio.com

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.